End-stage kidney disease due to haemolytic uraemic syndrome - Outcomes in 241 consecutive ANZDATA registry cases

BMC Nephrology

Volumn 13, Issue 1, 2012, Pages

  Tang, Wen ^a,b,c   Mohandas, Janaki ^a,c   McDonald, Stephen P ^a,d   Hawley, Carmel M ^a,c   Badve, Sunil V ^a,c   Boudville, Neil ^a,e   Brown, Fiona G ^a,f   Clayton, Philip A ^a,g,h   Wiggins, Kathryn J ^a,i   Bannister, Kym M ^a   Campbell, Scott B ^a,c   Johnson, David W ^a,c,j  

^a ANZDATA Registry   (Australia)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f MONASH MEDICAL CENTRE   (Australia)

^g ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^h UNIVERSITY OF SYDNEY   (Australia)

ⁱ ROYAL MELBOURNE HOSPITAL   (Australia)

^j PRINCESS ALEXANDRA HOSPITAL   (Australia)

more..

Author keywords

Chronic; Haemolytic uraemic syndrome; Kidney Failure; Outcomes; Renal function recovery; Renal transplantation; Thrombotic microangiopathy

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA AND NEW ZEALAND; CHILD; CONTROLLED STUDY; DISEASE REGISTRY; FEMALE; GRAFT SURVIVAL; HEMOLYTIC UREMIC SYNDROME; HUMAN; INFANT; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEWBORN; PRESCHOOL CHILD; PROPENSITY SCORE; RENAL REPLACEMENT THERAPY; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEW ZEALAND; REGISTRIES; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84870289555     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-13-164     Document Type: Article

References (25)

1. Atypical hemolytic-uremic syndrome. Noris M, Remuzzi G, N Engl J Med 2009 361 1676 1687 10.1056/NEJMra0902814 19846853
2. Thrombotic microangiopathy after kidney transplantation. Noris M, Remuzzi G, Am J Transplant 2010 10 1517 1523 10.1111/j.1600-6143.2010.03156.x 20642678
3. Escherichia coli O157:H7 and the hemolytic-uremic syndrome. Boyce TG, Swerdlow DL, Griffin PM, N Engl J Med 1995 333 364 368 10.1056/ NEJM199508103330608 7609755
4. Hemolytic uremic syndrome associated with Streptococcus pneumoniae. Begue R, Dennehy PH, Peter G, N Engl J Med 1991 325 133 134 2052051
5. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Besbas N, Karpman D, Landau D, Loirat C, Proesmans W, Remuzzi G, Rizzoni G, Taylor CM, de KN V, Zimmerhackl LB, Kidney Int 2006 70 423 431 16775594 (Pubitemid 44141568)
6. Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Medina PJ, Sipols JM, George JN, Curr Opin Hematol 2001 8 286 293 10.1097/00062752-200109000-00004 11604563 (Pubitemid 32826498)
7. Adult haemolytic and uraemic syndrome: causes and prognostic factors in the last decade. Tostivint I, Mougenot B, Flahault A, Vigneau C, Costa MA, Haymann JP, Sraer JD, Rondeau E, Nephrol Dial Transplant 2002 17 1228 1234 10.1093/ndt/17.7.1228 12105245 (Pubitemid 34812067)
8. The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: overview of pathogenesis (Experience of The Oklahoma TTP-HUS Registry, 1989-2007). George JN, Kidney Int Suppl 2009 75 Suppl 112 8 S10
9. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. Terrell DR, Williams LA, Vesely SK, Lammle B, Hovinga JA, George JN, J Thromb Haemost 2005 3 1432 1436 10.1111/j.1538-7836.2005.01436.x 15978100 (Pubitemid 41725200)
10. A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah. Siegler RL, Pavia AT, Christofferson RD, Milligan MK, Pediatrics 1994 94 35 40 8008534 (Pubitemid 24194093)
11. Outcome of end-stage renal disease in patients with rare causes of renal failure III. Systemic/vascular disorders. Nissenson AR, Port FK, Q J Med 1990 74 63 74 1970184 (Pubitemid 20036654)
12. Recurrence of hemolytic-uremic syndrome in renal transplant recipients: a meta-analysis. Ducloux D, Rebibou JM, Semhoun-Ducloux S, Jamali M, Fournier V, Bresson-Vautrin C, Chalopin JM, Transplantation 1998 65 1405 1407 10.1097/00007890-199805270-00023 9625029 (Pubitemid 28283109)
13. Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Ahmed A, Rich MW, Sanders PW, Perry GJ, Bakris GL, Zile MR, Love TE, Aban IB, Shlipak MG, Am J Cardiol 2007 99 393 398 10.1016/j.amjcard.2006.08.042 17261405 (Pubitemid 46151762)
14. Applying Cox regression to competing risks. Lunn M, McNeil D, Biometrics 1995 51 524 532 10.2307/2532940 7662841
15. A proportional hazards model for the subdistribution of competing risks in survival analysis. Fine JP, Gray RJ, J Am Stat Assoc 1999 94 496 509 10.1080/01621459.1999.10474144
16. Tutorial in biostatistics: competing risks and multi-state models. Putter H, Fiocco M, Geskus RB, Stat Med 2007 26 2389 2430 10.1002/sim.2712 17031868 (Pubitemid 46730255)
17. Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement. Coppo P, Bengoufa D, Veyradier A, Wolf M, Bussel A, Millot GA, Malot S, Heshmati F, Mira JP, Boulanger E, Medicine (Baltimore) 2004 83 233 244 10.1097/01.md.0000133622.03370.07 (Pubitemid 38955446)
18. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Vesely SK, George JN, Lammle B, Studt JD, Alberio L, El Harake MA, Raskob GE, Blood 2003 102 60 68 10.1182/blood-2003-01- 0193 12637323 (Pubitemid 36759636)
19. Late recovery of renal function in a woman with the hemolytic uremic syndrome. Ponticelli C, Maestri O, Imbasciati E, Brancaccio D, Rossi E, Clin Nephrol 1977 8 367 370 891050 (Pubitemid 8163814)
20. Recovery of renal function after long-term dialysis in hemolytic uremic syndrome. Brunner K, Bianchetti MG, Neuhaus TJ, Pediatr Nephrol 2004 19 229 231 10.1007/s00467-003-1337-4 14648326 (Pubitemid 38181019)
21. Atypical hemolytic-uremic syndrome (HUS) with recovery after a long-lasting anuria: a case report. Georgaki-Angelaki H, Stergiou N, Kapogiannis A, Orfanou I, Grapsa B, Roma E, Hippokratia 2011 15 90 92 21607045
22. Combined report on regular dialysis and transplantation in Europe, XIV, 1983. Kramer P, Broyer M, Brunner FP, Brynger H, Challah S, Oules R, Rizzoni G, Selwood NH, Wing AJ, Balas EA, Proc Eur Dial Transplant Assoc Eur Ren Assoc 1985 21 2 65 3887373
23. Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with peritoneal dialysis. Craven AM, Hawley CM, McDonald SP, Rosman JB, Brown FG, Johnson DW, Perit Dial Int 2007 27 184 191 17299156 (Pubitemid 46795874)
24. Recovery of renal function in end-stage renal failure-comparison between peritoneal dialysis and haemodialysis. Macdonald JA, McDonald SP, Hawley CM, Rosman J, Brown F, Wiggins KJ, Bannister K, Johnson DW, Nephrol Dial Transplant 2009 24 2825 2831 10.1093/ndt/gfp216 19443649
25. Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background. Bresin E, Daina E, Noris M, Castelletti F, Stefanov R, Hill P, Goodship TH, Remuzzi G, Clin J Am Soc Nephrol 2006 1 88 99 17699195